.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Merck
Covington
Deloitte
McKinsey
UBS
Boehringer Ingelheim
Argus Health
Cerilliant
Daiichi Sankyo

Generated: June 26, 2017

DrugPatentWatch Database Preview

Doxylamine succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for doxylamine succinate and what is the scope of doxylamine succinate freedom to operate?

Doxylamine succinate
is the generic ingredient in eight branded drugs marketed by Copley Pharm, Quantum Pharmics, Sanofi Aventis Us, Pfizer, Par Pharm, LNK, Chattem, Perrigo, Actavis Labs Fl Inc, and Duchesnay, and is included in twelve NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for doxylamine succinate. Thirty suppliers are listed for this compound.

Summary for Generic Name: doxylamine succinate

Tradenames:8
Patents:6
Applicants:10
NDAs:12
Drug Master File Entries: see list13
Suppliers / Packagers: see list30
Bulk Api Vendors: see list39
Clinical Trials: see list176
Patent Applications: see list1,025
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxylamine succinate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes9,526,703► SubscribeY ► Subscribe
Sanofi Aventis Us
DECAPRYN
doxylamine succinate
TABLET;ORAL006412-015Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Copley Pharm
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL088900-002Feb 12, 1988DISCNNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe
Par Pharm
DOXY-SLEEP-AID
doxylamine succinate
TABLET;ORAL070156-001Jul 2, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
US Department of Justice
Novartis
Accenture
Citi
Boehringer Ingelheim
US Army
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot